XNAS 11 Jul, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.22 per share. | 02 Jul 2025 | 200 | 37,082 (0%) | 0% | 159.2 | 31,845 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.11 per share. | 02 Jul 2025 | 1,092 | 35,990 (0%) | 0% | 160.1 | 174,835 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.23 per share. | 02 Jul 2025 | 208 | 35,782 (0%) | 0% | 161.2 | 33,535 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.29 per share. | 02 Jul 2025 | 189 | 35,782 (0%) | 0% | 161.3 | 30,483 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.11 per share. | 02 Jul 2025 | 1,011 | 35,971 (0%) | 0% | 160.1 | 161,869 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.14 per share. | 02 Jul 2025 | 300 | 36,982 (0%) | 0% | 159.1 | 47,742 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 167.56 per share. | 01 Jul 2025 | 2,651 | 8,118 (0%) | 0% | 167.6 | 444,189 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 01 Jul 2025 | 4,299 | 12,417 (0%) | 0% | 24.4 | 104,982 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 167.05 per share. | 01 Jul 2025 | 1,648 | 10,769 (0%) | 0% | 167.1 | 275,301 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,299 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 164.00 per share. | 01 Jul 2025 | 1,008 | 178,063 (0%) | 0% | 164.0 | 165,308 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.77 per share. | 01 Jul 2025 | 648 | 173,728 (0%) | 0% | 167.8 | 108,714 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.19 per share. | 01 Jul 2025 | 3,187 | 174,376 (0%) | 0% | 167.2 | 532,839 | Common Stck |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.83 per share. | 01 Jul 2025 | 500 | 177,563 (0%) | 0% | 165.8 | 82,917 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.79 per share. | 01 Jul 2025 | 291 | 130,205 (0%) | 0% | 167.8 | 48,827 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 163.88 per share. | 01 Jul 2025 | 400 | 132,805 (0%) | 0% | 163.9 | 65,551 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.98 per share. | 01 Jul 2025 | 200 | 132,605 (0%) | 0% | 166.0 | 33,197 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 01 Jul 2025 | 2,109 | 130,496 (0%) | 0% | 167.2 | 352,730 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 68,476 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 68,205 (0%) | 0% | - | Common Stock | |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 5,107 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 6,246 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 6,517 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 18,158 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 8,118 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 7,847 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 5,020 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.81 per share. | 16 Jun 2025 | 550 | 37,829 (0%) | 0% | 164.8 | 90,644 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.64 per share. | 16 Jun 2025 | 425 | 37,981 (0%) | 0% | 164.6 | 69,972 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.10 per share. | 16 Jun 2025 | 200 | 38,406 (0%) | 0% | 163.1 | 32,620 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.52 per share. | 16 Jun 2025 | 176 | 38,606 (0%) | 0% | 162.5 | 28,603 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.48 per share. | 16 Jun 2025 | 547 | 37,282 (0%) | 0% | 165.5 | 90,519 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.41 per share. | 16 Jun 2025 | 203 | 38,379 (0%) | 0% | 163.4 | 33,172 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.29 per share. | 16 Jun 2025 | 3,070 | 248,774 (0%) | 0% | 167.3 | 513,571 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.50 per share. | 16 Jun 2025 | 200 | 38,582 (0%) | 0% | 162.5 | 32,499 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.41 per share. | 16 Jun 2025 | 699 | 37,282 (0%) | 0% | 165.4 | 115,620 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 164.33 per share. | 10 Jun 2025 | 3,400 | 6,304 (0%) | 0% | 164.3 | 558,734 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 165.04 per share. | 10 Jun 2025 | 600 | 5,704 (0%) | 0% | 165.0 | 99,027 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 156.07 per share. | 02 Jun 2025 | 1,512 | 183,670 (0%) | 0% | 156.1 | 235,972 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 158.33 per share. | 02 Jun 2025 | 1,476 | 179,071 (0%) | 0% | 158.3 | 233,688 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 157.03 per share. | 02 Jun 2025 | 3,123 | 180,547 (0%) | 0% | 157.0 | 490,403 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 156.30 per share. | 02 Jun 2025 | 1,290 | 134,915 (0%) | 0% | 156.3 | 201,629 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 159.12 per share. | 02 Jun 2025 | 100 | 133,205 (0%) | 0% | 159.1 | 15,912 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.37 per share. | 02 Jun 2025 | 465 | 133,305 (0%) | 0% | 158.4 | 73,643 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 157.23 per share. | 02 Jun 2025 | 1,145 | 133,770 (0%) | 0% | 157.2 | 180,028 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 153.10 per share. | 15 May 2025 | 9,000 | 55,000 (0%) | 0% | 153.1 | 1,377,900 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 153.90 per share. | 15 May 2025 | 10,000 | 45,000 (0%) | 0% | 153.9 | 1,539,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 161.00 per share. | 15 May 2025 | 10,000 | 35,000 (0%) | 0% | 161 | 1,610,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.85 per share. | 15 May 2025 | 5,000 | 30,000 (0%) | 0% | 165.9 | 829,250 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 150.20 per share. | 15 May 2025 | 10,000 | 74,000 (0%) | 0% | 150.2 | 1,502,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 152.60 per share. | 15 May 2025 | 10,000 | 64,000 (0%) | 0% | 152.6 | 1,526,000 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 153.95 per share. | 09 May 2025 | 392 | 254,522 (0%) | 0% | 153.9 | 60,348 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.01 per share. | 09 May 2025 | 708 | 38,782 (0%) | 0% | 159.0 | 112,577 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.01 per share. | 09 May 2025 | 383 | 39,490 (0%) | 0% | 158.0 | 60,517 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 157.09 per share. | 09 May 2025 | 409 | 39,873 (0%) | 0% | 157.1 | 64,248 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.77 per share. | 09 May 2025 | 100 | 38,782 (0%) | 0% | 159.8 | 15,977 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.06 per share. | 09 May 2025 | 690 | 38,882 (0%) | 0% | 159.1 | 109,749 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 157.88 per share. | 09 May 2025 | 307 | 39,572 (0%) | 0% | 157.9 | 48,469 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 156.90 per share. | 09 May 2025 | 403 | 39,879 (0%) | 0% | 156.9 | 63,229 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.03 per share. | 09 May 2025 | 100 | 251,844 (0%) | 0% | 164.0 | 16,403 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.07 per share. | 09 May 2025 | 400 | 251,944 (0%) | 0% | 163.1 | 65,229 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.31 per share. | 09 May 2025 | 1,231 | 252,344 (0%) | 0% | 162.3 | 199,800 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.76 per share. | 09 May 2025 | 600 | 253,575 (0%) | 0% | 159.8 | 95,859 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.02 per share. | 09 May 2025 | 107 | 254,175 (0%) | 0% | 158.0 | 16,908 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.50 per share. | 09 May 2025 | 240 | 254,282 (0%) | 0% | 155.5 | 37,320 | Common Stock |
| Marcus Gail B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 4,000 | 4,299 | - | - | Stock Option (right to buy) | |
| Leonard Steven Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 148.25 per share. | 01 May 2025 | 2,009 | 190,153 (0%) | 0% | 148.3 | 297,837 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 148.25 per share. | 01 May 2025 | 853 | 138,352 (0%) | 0% | 148.3 | 126,460 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 152.04 per share. | 01 May 2025 | 331 | 136,205 (0%) | 0% | 152.0 | 50,325 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 152.04 per share. | 01 May 2025 | 770 | 185,182 (0%) | 0% | 152.0 | 117,071 | Common Stock |
| B. Gail Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 01 May 2025 | 4,000 | 13,704 (0%) | 0% | 24.4 | 97,680 | Common Stock |
| B. Marcus Gail | Director | Sale of securities on an exchange or to another person at price $ 153.06 per share. | 01 May 2025 | 1,450 | 9,704 (0%) | 0% | 153.1 | 221,941 | Common Stock |
| Leonard Steven Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 151.26 per share. | 01 May 2025 | 2,186 | 185,952 (0%) | 0% | 151.3 | 330,665 | Common Stock |
| B. Gail Marcus | Director | Sale of securities on an exchange or to another person at price $ 151.37 per share. | 01 May 2025 | 672 | 12,096 (0%) | 0% | 151.4 | 101,719 | Common Stock |
| B. Marcus Gail | Director | Sale of securities on an exchange or to another person at price $ 152.22 per share. | 01 May 2025 | 942 | 11,154 (0%) | 0% | 152.2 | 143,392 | Common Stock |
| Gail Marcus B. | Director | Sale of securities on an exchange or to another person at price $ 146.35 per share. | 01 May 2025 | 31 | 13,673 (0%) | 0% | 146.4 | 4,537 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 149.99 per share. | 01 May 2025 | 908 | 137,444 (0%) | 0% | 150.0 | 136,188 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 149.94 per share. | 01 May 2025 | 2,015 | 188,138 (0%) | 0% | 149.9 | 302,130 | Common Stock |
| Gail Marcus B. | Director | Sale of securities on an exchange or to another person at price $ 149.05 per share. | 01 May 2025 | 241 | 13,109 (0%) | 0% | 149.0 | 35,920 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 151.30 per share. | 01 May 2025 | 908 | 136,536 (0%) | 0% | 151.3 | 137,379 | Common Stock |
| Marcus Gail B. | Director | Sale of securities on an exchange or to another person at price $ 147.95 per share. | 01 May 2025 | 323 | 13,350 (0%) | 0% | 147.9 | 47,787 | Common Stock |
| B. Marcus Gail | Director | Sale of securities on an exchange or to another person at price $ 149.96 per share. | 01 May 2025 | 341 | 12,768 (0%) | 0% | 150.0 | 51,138 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 1,718 | 2,362,570 (3%) | 0% | 152.2 | 261,449 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 439 | 254,914 (0%) | 0% | 152.2 | 66,808 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 2,018 | 73,539 (0%) | 0% | 152.2 | 307,104 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 154.74 per share. | 28 Apr 2025 | 1,445 | 70,694 (0%) | 0% | 154.7 | 223,605 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 153.94 per share. | 28 Apr 2025 | 700 | 72,139 (0%) | 0% | 153.9 | 107,761 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.90 per share. | 28 Apr 2025 | 700 | 72,839 (0%) | 0% | 152.9 | 107,030 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 155.44 per share. | 28 Apr 2025 | 200 | 70,494 (0%) | 0% | 155.4 | 31,087 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 6,203 | 192,162 (0%) | 0% | 152.2 | 943,987 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 1,993 | 223,674 (0%) | 0% | 152.2 | 303,300 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Apr 2025 | 75 | 139,205 (0%) | 0% | 0 | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 2,206 | 139,280 (0%) | 0% | 152.2 | 335,714 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 1,709 | 155,237 (0%) | 0% | 152.2 | 260,080 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 164 | 66,062 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 142 | 46,260 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 185 | 4,103 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 116 | 16,015 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 1,250 | 2,500 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 150.74 per share. | 22 Apr 2025 | 495 | 76,312 (0%) | 0% | 150.7 | 74,616 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 1,250 | 76,807 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 145.35 per share. | 22 Apr 2025 | 603 | 75,557 (0%) | 0% | 145.3 | 87,645 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 144.31 per share. | 22 Apr 2025 | 308 | 76,160 (0%) | 0% | 144.3 | 44,446 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.46 per share. | 22 Apr 2025 | 194 | 75,557 (0%) | 0% | 152.5 | 29,577 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.45 per share. | 22 Apr 2025 | 561 | 75,751 (0%) | 0% | 152.4 | 85,524 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 21 Apr 2025 | 292 | 141,490 (0%) | 0% | 145.5 | 42,498 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 146.75 per share. | 21 Apr 2025 | 4 | 141,486 (0%) | 0% | 146.8 | 587 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 146.00 per share. | 21 Apr 2025 | 4 | 156,946 (0%) | 0% | 146 | 584 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 21 Apr 2025 | 339 | 156,950 (0%) | 0% | 145.5 | 49,338 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 190 | 255,439 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.00 per share. | 20 Apr 2025 | 1 | 255,353 (0%) | 0% | 146 | 146 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 85 | 255,354 (0%) | 0% | 145.5 | 12,371 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 190 | 571 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 1,521 | 77,078 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 602 | 76,476 (0%) | 0% | 145.5 | 87,615 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.12 per share. | 20 Apr 2025 | 8 | 76,468 (0%) | 0% | 146.1 | 1,169 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 1,521 | 4,566 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 1,643 | 198,386 (0%) | 0% | 145.5 | 239,122 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 3,386 | 10,158 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 146.05 per share. | 20 Apr 2025 | 21 | 198,365 (0%) | 0% | 146.0 | 3,067 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 3,386 | 200,029 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 856 | 2,568 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 856 | 226,137 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 464 | 225,673 (0%) | 0% | 145.5 | 67,531 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.17 per share. | 20 Apr 2025 | 6 | 225,667 (0%) | 0% | 146.2 | 877 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 132.04 per share. | 03 Apr 2025 | 1,220 | 257,099 (0%) | 0% | 132.0 | 161,091 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 141.28 per share. | 03 Apr 2025 | 100 | 40,282 (0%) | 0% | 141.3 | 14,128 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 137.08 per share. | 03 Apr 2025 | 260 | 41,522 (0%) | 0% | 137.1 | 35,641 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 138.55 per share. | 03 Apr 2025 | 490 | 41,032 (0%) | 0% | 138.5 | 67,889 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 03 Apr 2025 | 395 | 40,637 (0%) | 0% | 140.0 | 55,301 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 140.94 per share. | 03 Apr 2025 | 355 | 40,282 (0%) | 0% | 140.9 | 50,034 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 140.57 per share. | 03 Apr 2025 | 287 | 40,382 (0%) | 0% | 140.6 | 40,343 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 139.56 per share. | 03 Apr 2025 | 396 | 40,669 (0%) | 0% | 139.6 | 55,265 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 138.57 per share. | 03 Apr 2025 | 477 | 41,065 (0%) | 0% | 138.6 | 66,097 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 136.98 per share. | 03 Apr 2025 | 240 | 41,542 (0%) | 0% | 137.0 | 32,876 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 136.05 per share. | 03 Apr 2025 | 100 | 255,249 (0%) | 0% | 136.1 | 13,605 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 135.24 per share. | 03 Apr 2025 | 300 | 255,349 (0%) | 0% | 135.2 | 40,573 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 133.86 per share. | 03 Apr 2025 | 400 | 255,649 (0%) | 0% | 133.9 | 53,544 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 133.28 per share. | 03 Apr 2025 | 1,050 | 256,049 (0%) | 0% | 133.3 | 139,939 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 01 Apr 2025 | 2,870 | 13,704 (0%) | 0% | 24.4 | 70,085 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 140.17 per share. | 01 Apr 2025 | 1,512 | 11,794 (0%) | 0% | 140.2 | 211,944 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 139.33 per share. | 01 Apr 2025 | 398 | 13,306 (0%) | 0% | 139.3 | 55,455 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.86 per share. | 01 Apr 2025 | 1,130 | 10,834 (0%) | 0% | 7.9 | 8,882 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,870 | 8,299 | - | - | Stock Option (right to buy) | |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,130 | 0 | - | - | Stock Option (right to buy) | |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 142.82 per share. | 01 Apr 2025 | 197 | 9,704 (0%) | 0% | 142.8 | 28,136 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 142.25 per share. | 01 Apr 2025 | 365 | 9,901 (0%) | 0% | 142.3 | 51,923 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 141.13 per share. | 01 Apr 2025 | 1,528 | 10,266 (0%) | 0% | 141.1 | 215,644 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 141.90 per share. | 01 Apr 2025 | 439 | 141,782 (0%) | 0% | 141.9 | 62,294 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 140.70 per share. | 01 Apr 2025 | 1,270 | 142,221 (0%) | 0% | 140.7 | 178,684 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 139.78 per share. | 01 Apr 2025 | 1,291 | 143,491 (0%) | 0% | 139.8 | 180,450 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 6,250 | 78,119 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.35 per share. | 28 Mar 2025 | 68 | 75,557 (0%) | 0% | 138.4 | 9,408 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.41 per share. | 28 Mar 2025 | 2,494 | 75,625 (0%) | 0% | 138.4 | 345,195 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 140.20 per share. | 28 Mar 2025 | 8,027 | 201,999 (0%) | 0% | 140.2 | 1,125,400 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 139.39 per share. | 28 Mar 2025 | 2,515 | 210,026 (0%) | 0% | 139.4 | 350,572 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 138.42 per share. | 28 Mar 2025 | 252 | 212,541 (0%) | 0% | 138.4 | 34,881 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 18,750 | 222,104 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 138.41 per share. | 28 Mar 2025 | 9,311 | 212,793 (0%) | 0% | 138.4 | 1,288,736 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 18,750 | 18,750 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 142.28 per share. | 28 Mar 2025 | 1,334 | 196,643 (0%) | 0% | 142.3 | 189,801 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 141.11 per share. | 28 Mar 2025 | 4,022 | 197,977 (0%) | 0% | 141.1 | 567,557 | Common Stock |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 2,877 | 2,877 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 2,500 | 2,500 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.38 per share. | 28 Mar 2025 | 37 | 225,281 (0%) | 0% | 138.4 | 5,120 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.41 per share. | 28 Mar 2025 | 1,367 | 225,318 (0%) | 0% | 138.4 | 189,207 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 2,500 | 226,685 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 149.67 per share. | 17 Mar 2025 | 3 | 2,364,288 (3%) | 0% | 149.7 | 449 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 1,124 | 2,364,291 (3%) | 0% | 146.0 | 164,135 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.81 per share. | 17 Mar 2025 | 630 | 258,319 (0%) | 0% | 146.8 | 92,493 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.78 per share. | 17 Mar 2025 | 430 | 41,782 (0%) | 0% | 146.8 | 63,117 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.09 per share. | 17 Mar 2025 | 1,070 | 42,212 (0%) | 0% | 145.1 | 155,251 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.60 per share. | 17 Mar 2025 | 53 | 258,949 (0%) | 0% | 145.6 | 7,717 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 181 | 261,019 (0%) | 0% | 146.0 | 26,431 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.17 per share. | 17 Mar 2025 | 2,017 | 259,002 (0%) | 0% | 145.2 | 292,817 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.78 per share. | 17 Mar 2025 | 490 | 41,782 (0%) | 0% | 146.8 | 71,921 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.21 per share. | 17 Mar 2025 | 1,010 | 42,272 (0%) | 0% | 145.2 | 146,664 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 149.50 per share. | 17 Mar 2025 | 2 | 71,869 (0%) | 0% | 149.5 | 299 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 790 | 71,871 (0%) | 0% | 146.0 | 115,362 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 6,702 | 203,354 (0%) | 0% | 146.0 | 978,678 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 926 | 224,187 (0%) | 0% | 146.0 | 135,222 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 149.50 per share. | 17 Mar 2025 | 2 | 224,185 (0%) | 0% | 149.5 | 299 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 149.67 per share. | 17 Mar 2025 | 3 | 144,782 (0%) | 0% | 149.7 | 449 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 1,023 | 144,785 (0%) | 0% | 146.0 | 149,386 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 793 | 157,291 (0%) | 0% | 146.0 | 115,800 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 149.50 per share. | 17 Mar 2025 | 2 | 157,289 (0%) | 0% | 149.5 | 299 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,893 | 2,415,415 (3%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 12 Mar 2025 | 13,935 | 2,365,715 (3%) | 0% | 148.4 | 2,067,696 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 147.64 per share. | 12 Mar 2025 | 29,967 | 2,379,650 (3%) | 0% | 147.6 | 4,424,187 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 146.58 per share. | 12 Mar 2025 | 4,798 | 2,409,617 (3%) | 0% | 146.6 | 703,296 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 145.37 per share. | 12 Mar 2025 | 1,000 | 2,414,415 (3%) | 0% | 145.4 | 145,369 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 149.00 per share. | 12 Mar 2025 | 300 | 2,365,415 (3%) | 0% | 149 | 44,700 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 411 | 261,200 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,032 | 72,661 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 145.86 per share. | 12 Mar 2025 | 1,014 | 12,690 (0%) | 0% | 145.9 | 147,907 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 149.27 per share. | 12 Mar 2025 | 381 | 9,704 (0%) | 0% | 149.3 | 56,873 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 148.71 per share. | 12 Mar 2025 | 1,682 | 10,085 (0%) | 0% | 148.7 | 250,127 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 147.20 per share. | 12 Mar 2025 | 923 | 11,767 (0%) | 0% | 147.2 | 135,867 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.86 per share. | 12 Mar 2025 | 4,000 | 13,704 (0%) | 0% | 7.9 | 31,440 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 4,000 | 1,130 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 6,702 | 210,056 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 1,740 | 225,113 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,040 | 145,808 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,040 | 158,084 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.75 per share. | 05 Mar 2025 | 10,320 | 204,254 (0%) | 0% | 144.7 | 1,493,794 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.02 per share. | 05 Mar 2025 | 33,776 | 214,574 (0%) | 0% | 144.0 | 4,864,284 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 142.79 per share. | 05 Mar 2025 | 30,298 | 248,350 (0%) | 0% | 142.8 | 4,326,194 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 141.91 per share. | 05 Mar 2025 | 11,978 | 278,648 (0%) | 0% | 141.9 | 1,699,855 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 145.42 per share. | 05 Mar 2025 | 900 | 203,354 (0%) | 0% | 145.4 | 130,878 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 144.12 per share. | 05 Mar 2025 | 1,700 | 144,168 (0%) | 0% | 144.1 | 245,009 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 143.05 per share. | 05 Mar 2025 | 2,700 | 145,868 (0%) | 0% | 143.1 | 386,239 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 142.08 per share. | 05 Mar 2025 | 1,200 | 148,568 (0%) | 0% | 142.1 | 170,499 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 144.97 per share. | 05 Mar 2025 | 400 | 143,768 (0%) | 0% | 145.0 | 57,988 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.82 per share. | 26 Feb 2025 | 50 | 263,439 (0%) | 0% | 155.8 | 7,791 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.64 per share. | 26 Feb 2025 | 96 | 43,282 (0%) | 0% | 162.6 | 15,613 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.64 per share. | 26 Feb 2025 | 296 | 43,378 (0%) | 0% | 161.6 | 47,846 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.85 per share. | 26 Feb 2025 | 744 | 43,674 (0%) | 0% | 160.9 | 119,674 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.88 per share. | 26 Feb 2025 | 292 | 44,418 (0%) | 0% | 158.9 | 46,394 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.67 per share. | 26 Feb 2025 | 72 | 44,710 (0%) | 0% | 155.7 | 11,208 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.64 per share. | 26 Feb 2025 | 100 | 43,282 (0%) | 0% | 162.6 | 16,264 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.58 per share. | 26 Feb 2025 | 336 | 43,382 (0%) | 0% | 161.6 | 54,290 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.76 per share. | 26 Feb 2025 | 704 | 43,718 (0%) | 0% | 160.8 | 113,173 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.77 per share. | 26 Feb 2025 | 296 | 44,422 (0%) | 0% | 158.8 | 46,995 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.66 per share. | 26 Feb 2025 | 64 | 44,718 (0%) | 0% | 155.7 | 9,962 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.06 per share. | 26 Feb 2025 | 590 | 260,789 (0%) | 0% | 162.1 | 95,617 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.04 per share. | 26 Feb 2025 | 1,280 | 261,379 (0%) | 0% | 161.0 | 206,126 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.24 per share. | 26 Feb 2025 | 580 | 262,659 (0%) | 0% | 159.2 | 92,361 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 157.80 per share. | 26 Feb 2025 | 200 | 263,239 (0%) | 0% | 157.8 | 31,561 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 177.77 per share. | 05 Feb 2025 | 1,632 | 149,768 (0%) | 0% | 177.8 | 290,121 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,522 | 151,400 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,675 | 149,878 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 177.77 per share. | 05 Feb 2025 | 663 | 156,044 (0%) | 0% | 177.8 | 117,862 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,675 | 156,707 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 133 | 65,898 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 114 | 46,118 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 151 | 3,918 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 29,345 | 2,412,522 (3%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 3,549 | 263,489 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 92 | 15,899 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 178.19 per share. | 31 Jan 2025 | 1,500 | 70,629 (0%) | 0% | 178.2 | 267,284 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 173.05 per share. | 31 Jan 2025 | 400 | 114,131 (0%) | 0% | 173.1 | 69,220 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 175.39 per share. | 31 Jan 2025 | 3,500 | 110,631 (0%) | 0% | 175.4 | 613,881 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 176.61 per share. | 31 Jan 2025 | 17,140 | 93,491 (0%) | 0% | 176.6 | 3,027,114 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 177.25 per share. | 31 Jan 2025 | 21,362 | 72,129 (0%) | 0% | 177.2 | 3,786,363 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 12,720 | 114,531 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,682 | 290,626 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,353 | 223,373 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 12,720 | 148,203 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 11,832 | 155,032 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,115 | 103,699 (0%) | 0% | 165.9 | 516,681 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.33 per share. | 29 Jan 2025 | 3 | 263,821 (0%) | 0% | 167.3 | 502 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,805 | 263,824 (0%) | 0% | 165.9 | 631,130 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.43 per share. | 29 Jan 2025 | 7 | 253,944 (0%) | 0% | 167.4 | 1,172 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 9,870 | 253,951 (0%) | 0% | 165.9 | 1,637,124 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,730 | 213,022 (0%) | 0% | 165.9 | 618,690 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 2 | 213,020 (0%) | 0% | 167 | 334 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,041 | 216,752 (0%) | 0% | 165.9 | 172,669 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 4,020 | 135,486 (0%) | 0% | 165.9 | 666,792 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.33 per share. | 29 Jan 2025 | 3 | 135,483 (0%) | 0% | 167.3 | 502 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,178 | 139,056 (0%) | 0% | 165.9 | 195,393 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,115 | 143,202 (0%) | 0% | 165.9 | 516,681 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 167.50 per share. | 29 Jan 2025 | 2 | 143,200 (0%) | 0% | 167.5 | 335 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 913 | 146,317 (0%) | 0% | 165.9 | 151,438 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 5,999 | 2,383,181 (3%) | 0% | 165.9 | 995,046 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 29 Jan 2025 | 4 | 2,383,177 (3%) | 0% | 167.3 | 669 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 176.60 per share. | 29 Jan 2025 | 163 | 259,940 (0%) | 0% | 176.6 | 28,786 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 1 | 260,103 (0%) | 0% | 167 | 167 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,053 | 260,104 (0%) | 0% | 165.9 | 174,660 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 2 | 103,697 (0%) | 0% | 167 | 334 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 1 | 106,814 (0%) | 0% | 167 | 167 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,217 | 106,815 (0%) | 0% | 165.9 | 201,862 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 176.60 per share. | 29 Jan 2025 | 1,886 | 101,811 (0%) | 0% | 176.6 | 333,068 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jan 2025 | 588 | 261,157 (0%) | 0% | 0 | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 161.87 per share. | 27 Jan 2025 | 1,442 | 108,032 (0%) | 0% | 161.9 | 233,417 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.80 per share. | 22 Jan 2025 | 687 | 109,733 (0%) | 0% | 171.8 | 118,027 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 1,250 | 110,915 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.09 per share. | 22 Jan 2025 | 495 | 110,420 (0%) | 0% | 171.1 | 84,690 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 172.44 per share. | 22 Jan 2025 | 259 | 109,474 (0%) | 0% | 172.4 | 44,662 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 171.95 per share. | 22 Jan 2025 | 62 | 140,684 (0%) | 0% | 172.0 | 10,661 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 22 Jan 2025 | 24,799 | 140,746 (0%) | 0% | 164.9 | 4,090,565 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 171.96 per share. | 22 Jan 2025 | 53 | 147,230 (0%) | 0% | 172.0 | 9,114 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 22 Jan 2025 | 21,175 | 147,283 (0%) | 0% | 164.9 | 3,492,791 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 191 | 761 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 191 | 262,572 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 144 | 262,716 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 964 | 261,752 (0%) | 0% | 164.9 | 159,011 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 171.86 per share. | 20 Jan 2025 | 7 | 261,745 (0%) | 0% | 171.9 | 1,203 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 144 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,145 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,522 | 134,451 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,145 | 135,596 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 25,867 | 109,729 (0%) | 0% | 164.9 | 4,266,731 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.95 per share. | 20 Jan 2025 | 64 | 109,665 (0%) | 0% | 172.0 | 11,005 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,522 | 6,087 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,775 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 3,386 | 13,544 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 171.97 per share. | 20 Jan 2025 | 194 | 267,629 (0%) | 0% | 172.0 | 33,362 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 78,359 | 267,823 (0%) | 0% | 164.9 | 12,925,223 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,775 | 346,182 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 3,386 | 344,407 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 644 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 21,985 | 217,847 (0%) | 0% | 164.9 | 3,626,399 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.94 per share. | 20 Jan 2025 | 54 | 217,793 (0%) | 0% | 171.9 | 9,285 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 644 | 239,832 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 856 | 239,188 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 856 | 3,424 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 3,043 | 257,415 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 4,966 | 262,381 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 3,043 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 24,348 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 24,348 | 93,199 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 39,730 | 132,929 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 101,812 | 341,021 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 54,175 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 54,175 | 239,209 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 13,696 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 24,832 | 238,332 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 13,696 | 213,500 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 9,130 | 126,127 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 29,798 | 155,925 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 9,620 | 165,545 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 10,822 | 168,458 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 13,696 | 127,838 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 29,798 | 157,636 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.71 per share. | 02 Jan 2025 | 1,230 | 255,842 (0%) | 0% | 158.7 | 195,212 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.65 per share. | 02 Jan 2025 | 900 | 254,942 (0%) | 0% | 159.7 | 143,688 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.67 per share. | 02 Jan 2025 | 570 | 254,372 (0%) | 0% | 160.7 | 91,581 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.73 per share. | 02 Jan 2025 | 641 | 45,641 (0%) | 0% | 158.7 | 101,749 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.69 per share. | 02 Jan 2025 | 555 | 45,086 (0%) | 0% | 159.7 | 88,628 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.68 per share. | 02 Jan 2025 | 304 | 44,782 (0%) | 0% | 160.7 | 48,848 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.73 per share. | 02 Jan 2025 | 480 | 45,802 (0%) | 0% | 158.7 | 76,192 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.76 per share. | 02 Jan 2025 | 732 | 45,070 (0%) | 0% | 159.8 | 116,947 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.70 per share. | 02 Jan 2025 | 288 | 44,782 (0%) | 0% | 160.7 | 46,281 | Common Stock |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 159.60 per share. | 20 Dec 2024 | 668 | 114,142 (0%) | 0% | 159.6 | 106,616 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 159.60 per share. | 20 Dec 2024 | 2,423 | 116,997 (0%) | 0% | 159.6 | 386,721 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 1,675 | 116,381 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 1,675 | 114,811 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 158.00 per share. | 20 Dec 2024 | 1 | 114,810 (0%) | 0% | 158 | 158 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 3,044 | 119,425 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.33 per share. | 20 Dec 2024 | 3 | 119,420 (0%) | 0% | 158.3 | 475 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.00 per share. | 20 Dec 2024 | 2 | 119,423 (0%) | 0% | 158 | 316 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2024 | 81 | 114,706 (0%) | 0% | 0 | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2024 | 125 | 114,787 (0%) | 0% | 0 | Common Stock | |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.07 per share. | 18 Dec 2024 | 852 | 46,778 (0%) | 0% | 167.1 | 142,347 | Common Srock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 168.15 per share. | 18 Dec 2024 | 537 | 257,072 (0%) | 0% | 168.1 | 90,294 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 18 Dec 2024 | 1,825 | 257,609 (0%) | 0% | 167.2 | 305,231 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 166.01 per share. | 18 Dec 2024 | 152 | 47,630 (0%) | 0% | 166.0 | 25,233 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.97 per share. | 18 Dec 2024 | 338 | 259,434 (0%) | 0% | 166.0 | 56,099 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 168.02 per share. | 18 Dec 2024 | 496 | 46,282 (0%) | 0% | 168.0 | 83,339 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 166.18 per share. | 18 Dec 2024 | 238 | 47,544 (0%) | 0% | 166.2 | 39,550 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.18 per share. | 18 Dec 2024 | 959 | 46,585 (0%) | 0% | 167.2 | 160,325 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 168.04 per share. | 18 Dec 2024 | 303 | 46,282 (0%) | 0% | 168.0 | 50,917 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 167.39 per share. | 13 Dec 2024 | 4,927 | 2,394,480 (3%) | 0% | 167.4 | 824,722 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 164.61 per share. | 13 Dec 2024 | 28,681 | 2,520,499 (3%) | 0% | 164.6 | 4,721,211 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.45 per share. | 13 Dec 2024 | 75,323 | 2,445,176 (3%) | 0% | 165.4 | 12,462,190 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 166.45 per share. | 13 Dec 2024 | 45,769 | 2,399,407 (3%) | 0% | 166.5 | 7,618,346 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 168.35 per share. | 13 Dec 2024 | 5,300 | 2,389,180 (3%) | 0% | 168.4 | 892,280 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 05 Dec 2024 | 68,496 | 2,549,180 (3%) | 0% | 5.4 | 369,556 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2024 | 68,496 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 169.78 per share. | 02 Dec 2024 | 40,171 | 1,236,006 (1%) | 0% | 169.8 | 6,820,228 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 168.73 per share. | 02 Dec 2024 | 16,853 | 1,276,177 (1%) | 0% | 168.7 | 2,843,578 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 166.88 per share. | 02 Dec 2024 | 8,783 | 1,303,477 (1%) | 0% | 166.9 | 1,465,667 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 167.59 per share. | 02 Dec 2024 | 10,447 | 1,293,030 (1%) | 0% | 167.6 | 1,750,792 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 170.54 per share. | 02 Dec 2024 | 11,219 | 1,224,787 (1%) | 0% | 170.5 | 1,913,298 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.55 per share. | 25 Nov 2024 | 400 | 84,000 (0%) | 0% | 165.6 | 66,220 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 163.25 per share. | 25 Nov 2024 | 660 | 85,340 (0%) | 0% | 163.2 | 107,744 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 164.24 per share. | 25 Nov 2024 | 940 | 84,400 (0%) | 0% | 164.2 | 154,384 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 169.94 per share. | 25 Nov 2024 | 311 | 86,000 (0%) | 0% | 169.9 | 52,851 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 167.89 per share. | 25 Nov 2024 | 1,089 | 86,911 (0%) | 0% | 167.9 | 182,831 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 168.91 per share. | 25 Nov 2024 | 600 | 86,311 (0%) | 0% | 168.9 | 101,346 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 159.83 per share. | 19 Nov 2024 | 7,582 | 11,804 (0%) | 0% | 159.8 | 1,211,842 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 160.52 per share. | 19 Nov 2024 | 2,100 | 9,704 (0%) | 0% | 160.5 | 337,089 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 15 Nov 2024 | 15,230 | 53,037 (0%) | 0% | 24.4 | 371,917 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 148.74 per share. | 15 Nov 2024 | 2,106 | 17,790 (0%) | 0% | 148.7 | 313,250 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 147.31 per share. | 15 Nov 2024 | 9,467 | 19,896 (0%) | 0% | 147.3 | 1,394,620 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 146.25 per share. | 15 Nov 2024 | 1,770 | 29,363 (0%) | 0% | 146.3 | 258,871 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 145.21 per share. | 15 Nov 2024 | 16,404 | 31,133 (0%) | 0% | 145.2 | 2,381,997 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 144.26 per share. | 15 Nov 2024 | 5,500 | 47,537 (0%) | 0% | 144.3 | 793,419 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.83 per share. | 15 Nov 2024 | 22,000 | 37,807 (0%) | 0% | 22.8 | 502,260 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 15,230 | 0 | - | - | Stock Option (right to buy) | |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 22,000 | 0 | - | - | Stock Option (right to buy) | |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 149.98 per share. | 15 Nov 2024 | 1,983 | 15,807 (0%) | 0% | 150.0 | 297,408 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 15 Nov 2024 | 440 | 185,034 (0%) | 0% | 150 | 66,000 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 148.92 per share. | 15 Nov 2024 | 351 | 185,474 (0%) | 0% | 148.9 | 52,272 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 147.83 per share. | 15 Nov 2024 | 1,052 | 185,825 (0%) | 0% | 147.8 | 155,517 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 146.35 per share. | 15 Nov 2024 | 100 | 186,877 (0%) | 0% | 146.4 | 14,635 | Common Stok |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 145.29 per share. | 15 Nov 2024 | 1,800 | 186,977 (0%) | 0% | 145.3 | 261,515 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.44 per share. | 15 Nov 2024 | 985 | 188,777 (0%) | 0% | 144.4 | 142,270 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 157.86 per share. | 14 Nov 2024 | 791 | 20,307 (0%) | 0% | 157.9 | 124,865 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 162.04 per share. | 14 Nov 2024 | 200 | 19,386 (0%) | 0% | 162.0 | 32,408 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 159.85 per share. | 14 Nov 2024 | 371 | 19,586 (0%) | 0% | 159.9 | 59,306 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 159.19 per share. | 14 Nov 2024 | 350 | 19,957 (0%) | 0% | 159.2 | 55,716 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 156.75 per share. | 14 Nov 2024 | 500 | 21,098 (0%) | 0% | 156.8 | 78,377 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 153.52 per share. | 13 Nov 2024 | 64 | 51,857 (0%) | 0% | 153.5 | 9,825 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.02 per share. | 13 Nov 2024 | 4,075 | 47,782 (0%) | 0% | 160.0 | 652,065 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.40 per share. | 13 Nov 2024 | 458 | 51,857 (0%) | 0% | 154.4 | 70,715 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.93 per share. | 13 Nov 2024 | 3,617 | 52,315 (0%) | 0% | 152.9 | 553,134 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.02 per share. | 13 Nov 2024 | 4,075 | 47,782 (0%) | 0% | 160.0 | 652,083 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.78 per share. | 13 Nov 2024 | 4,011 | 51,921 (0%) | 0% | 152.8 | 612,806 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.11 per share. | 13 Nov 2024 | 11,974 | 259,772 (0%) | 0% | 154.1 | 1,845,296 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.69 per share. | 13 Nov 2024 | 8,026 | 271,746 (0%) | 0% | 152.7 | 1,225,472 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 10,000 | 68,496 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 130,000 | 78,496 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 11 Nov 2024 | 130,000 | 2,470,684 (3%) | 0% | 5.4 | 701,389 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 11 Nov 2024 | 10,000 | 2,480,684 (3%) | 0% | 5.4 | 53,953 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 129.78 per share. | 08 Nov 2024 | 360 | 282,112 (0%) | 0% | 129.8 | 46,720 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 130.40 per share. | 08 Nov 2024 | 736 | 56,696 (0%) | 0% | 130.4 | 95,971 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.14 per share. | 08 Nov 2024 | 764 | 55,932 (0%) | 0% | 131.1 | 100,189 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 130.47 per share. | 08 Nov 2024 | 998 | 56,434 (0%) | 0% | 130.5 | 130,210 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.24 per share. | 08 Nov 2024 | 412 | 56,022 (0%) | 0% | 131.2 | 54,070 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.84 per share. | 08 Nov 2024 | 90 | 55,932 (0%) | 0% | 131.8 | 11,866 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.85 per share. | 08 Nov 2024 | 169 | 279,772 (0%) | 0% | 131.9 | 22,283 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 130.89 per share. | 08 Nov 2024 | 2,171 | 279,941 (0%) | 0% | 130.9 | 284,162 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 126.45 per share. | 31 Oct 2024 | 1,866 | 68,851 (0%) | 0% | 126.5 | 235,956 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 1,238 | 71,471 (0%) | 0% | 118.2 | 146,345 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 119.93 per share. | 28 Oct 2024 | 754 | 70,717 (0%) | 0% | 119.9 | 90,427 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 3,960 | 189,762 (0%) | 0% | 118.2 | 468,114 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 1,057 | 206,027 (0%) | 0% | 118.2 | 124,948 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 1,196 | 110,695 (0%) | 0% | 118.2 | 141,380 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 929 | 113,136 (0%) | 0% | 118.2 | 109,818 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 178 | 65,765 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 153 | 46,004 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 203 | 3,767 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 124 | 15,807 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 119.19 per share. | 24 Oct 2024 | 914 | 73,400 (0%) | 0% | 119.2 | 108,940 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 118.81 per share. | 24 Oct 2024 | 691 | 72,709 (0%) | 0% | 118.8 | 82,098 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 119.09 per share. | 22 Oct 2024 | 496 | 74,314 (0%) | 0% | 119.1 | 59,068 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2024 | 1,250 | 5,000 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2024 | 1,250 | 74,810 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 21 Oct 2024 | 294 | 112,147 (0%) | 0% | 120.8 | 35,503 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 21 Oct 2024 | 256 | 111,891 (0%) | 0% | 120.1 | 30,738 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 21 Oct 2024 | 342 | 114,264 (0%) | 0% | 120.8 | 41,299 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 21 Oct 2024 | 199 | 114,065 (0%) | 0% | 120.1 | 23,894 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 190 | 282,231 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 143 | 144 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 190 | 952 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 143 | 282,374 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,522 | 73,477 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,145 | 1,145 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,522 | 7,609 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 20 Oct 2024 | 454 | 73,560 (0%) | 0% | 120.1 | 54,512 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 20 Oct 2024 | 608 | 74,014 (0%) | 0% | 120.8 | 73,420 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,145 | 74,622 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,775 | 196,324 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 20 Oct 2024 | 1,709 | 194,615 (0%) | 0% | 120.8 | 206,375 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 20 Oct 2024 | 893 | 193,722 (0%) | 0% | 120.1 | 107,223 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 3,386 | 16,930 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,775 | 1,775 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 3,386 | 194,549 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 20 Oct 2024 | 467 | 207,433 (0%) | 0% | 120.8 | 56,394 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 644 | 644 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 856 | 4,280 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 20 Oct 2024 | 349 | 207,084 (0%) | 0% | 120.1 | 41,904 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 644 | 207,900 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 856 | 207,256 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 130.40 per share. | 15 Oct 2024 | 4,523 | 191,163 (0%) | 0% | 130.4 | 589,797 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 124.82 per share. | 01 Oct 2024 | 876 | 283,865 (0%) | 0% | 124.8 | 109,346 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 125.95 per share. | 01 Oct 2024 | 1,025 | 57,432 (0%) | 0% | 126.0 | 129,100 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 124.89 per share. | 01 Oct 2024 | 475 | 58,457 (0%) | 0% | 124.9 | 59,322 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 126.27 per share. | 01 Oct 2024 | 729 | 57,432 (0%) | 0% | 126.3 | 92,051 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 125.23 per share. | 01 Oct 2024 | 771 | 58,161 (0%) | 0% | 125.2 | 96,550 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 126.42 per share. | 01 Oct 2024 | 427 | 282,041 (0%) | 0% | 126.4 | 53,982 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 125.83 per share. | 01 Oct 2024 | 1,397 | 282,468 (0%) | 0% | 125.8 | 175,785 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 127.38 per share. | 18 Sep 2024 | 1,922 | 285,519 (0%) | 0% | 127.4 | 244,822 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 127.38 per share. | 18 Sep 2024 | 6,404 | 62,178 (0%) | 0% | 127.4 | 815,728 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 128.06 per share. | 18 Sep 2024 | 3,246 | 58,932 (0%) | 0% | 128.1 | 415,678 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 128.07 per share. | 18 Sep 2024 | 3,066 | 58,932 (0%) | 0% | 128.1 | 392,677 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 127.39 per share. | 18 Sep 2024 | 6,584 | 61,998 (0%) | 0% | 127.4 | 838,704 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 128.06 per share. | 18 Sep 2024 | 778 | 284,741 (0%) | 0% | 128.1 | 99,628 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 126.66 per share. | 16 Sep 2024 | 1,042 | 199,668 (0%) | 0% | 126.7 | 131,984 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 130.93 per share. | 16 Sep 2024 | 500 | 195,686 (0%) | 0% | 130.9 | 65,466 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 129.90 per share. | 16 Sep 2024 | 598 | 196,186 (0%) | 0% | 129.9 | 77,678 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 128.87 per share. | 16 Sep 2024 | 1,626 | 196,784 (0%) | 0% | 128.9 | 209,539 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 127.83 per share. | 16 Sep 2024 | 1,258 | 198,410 (0%) | 0% | 127.8 | 160,807 | Common Stock |
| Rowan E. Chapman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 2,614 | 0 | - | - | Stock Option (right to buy) | |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 127.68 per share. | 13 Sep 2024 | 2,614 | 7,969 (0%) | 0% | 127.7 | 333,756 | Common Stock |
| Rowan E. Chapman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.14 per share. | 13 Sep 2024 | 2,614 | 10,583 (0%) | 0% | 94.1 | 246,082 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 121.01 per share. | 15 Aug 2024 | 12,000 | 287,441 (0%) | 0% | 121.0 | 1,452,125 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 15 Aug 2024 | 577 | 200,710 (0%) | 0% | 120 | 69,240 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 118.79 per share. | 15 Aug 2024 | 5,006 | 201,287 (0%) | 0% | 118.8 | 594,655 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 114.11 per share. | 12 Aug 2024 | 781 | 300,141 (0%) | 0% | 114.1 | 89,119 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 112.80 per share. | 12 Aug 2024 | 1,219 | 300,922 (0%) | 0% | 112.8 | 137,507 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 115.70 per share. | 12 Aug 2024 | 220 | 299,441 (0%) | 0% | 115.7 | 25,454 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 115.07 per share. | 12 Aug 2024 | 480 | 299,661 (0%) | 0% | 115.1 | 55,234 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 116.67 per share. | 12 Aug 2024 | 3,956 | 114,606 (0%) | 0% | 116.7 | 461,547 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 10,000 | 118,562 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 08 Aug 2024 | 190,000 | 1,480,648 (1%) | 0% | 5.4 | 1,025,107 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 190,000 | 208,496 | - | - | Stock Option (right to buy) | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 99.65 per share. | 29 Jul 2024 | 1,866 | 71,955 (0%) | 0% | 99.7 | 185,947 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 1,238 | 73,821 (0%) | 0% | 102.8 | 127,224 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 4,084 | 206,293 (0%) | 0% | 102.8 | 419,695 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 1,057 | 206,400 (0%) | 0% | 102.8 | 108,623 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 1,196 | 112,441 (0%) | 0% | 102.8 | 122,908 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 29 Jul 2024 | 100 | 108,562 (0%) | 0% | 5.4 | 540 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 100 | 0 | - | - | Stock Option (right to buy) | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 929 | 108,462 (0%) | 0% | 102.8 | 95,469 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 206 | 65,587 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 177 | 45,851 (0%) | 0% | - | Common Stock |